Stockscreener 앱 받기
11.27
6.16%
-0.74
Avalo Therapeutics Inc (AVTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Costs And Expenses |
50.79%
31.52
|
20.90 | 19.80 | 19.20 | 19.32 |
| Operating Income/Loss |
50.79%
-31.52
|
-20.90 | -19.74 | -19.20 | -19.32 |
| Nonoperating Income/Loss |
475.92%
-4.823
|
1.283 | 6.152 | -11.42 | -1.433 |
| Income/Loss From Continuing Operations Before Tax |
85.24%
-36.34
|
-19.62 | -13.59 | -30.61 | -20.75 |
| Income Tax Expense/Benefit, Deferred |
41.67%
0.017
|
0.012 | 0.131 | 0.01 | 0.016 |
| Income Tax Expense/Benefit |
50.00%
0.018
|
0.012 | 0.13 | 0.011 | 0.016 |
Net Income/Loss
|
85.22%
-36.36
|
-19.63 | -13.72 | -30.62 | -20.77 |
| Basic Average Shares |
116.85%
43.60
|
20.11 | - | 14.00 | 10.83 |
| Diluted Average Shares |
116.85%
43.60
|
20.11 | - | 14.00 | 10.83 |
| Basic Earnings Per Share |
15.31%
-0.83
|
-0.98 | - | -2.19 | -1.92 |
| Diluted Earnings Per Share |
15.31%
-0.83
|
-0.98 | - | -2.19 | -1.92 |
1.74%
자본화:
|
볼륨(24시간):